Kinaset Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Kinaset Therapeutics's estimated annual revenue is currently $3.2M per year.(i)
  • Kinaset Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Kinaset Therapeutics has 16 Employees.(i)
  • Kinaset Therapeutics grew their employee count by 7% last year.

Kinaset Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is Kinaset Therapeutics?

At Kinaset Therapeutics, we intend to develop novel respiratory therapeutics that can positively impact people affected by intractable diseases. Our novel lead asset and experienced team combine a potentially best in class approach to treating severe asthma

keywords:N/A

N/A

Total Funding

16

Number of Employees

$3.2M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kinaset Therapeutics News

2020-12-01 - Kinaset Therapeutics launches with $40M

Kinaset Therapeutics, a developer of treatments for respiratory disorders, has raised $40 million from 5AM Ventures, Atlas Venture and Gimv. The biopharma company plans to begin Phase I and I-B clinical trials of a drug designed to treat severe asthma in the first half of next year. View round

2020-11-30 - Kinaset Therapeutics Launches with a $40M Series A Financing

MEDFIELD, Mass.--(BUSINESS WIRE)--Kinaset Therapeutics, Inc., a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM Ventures, Atlas Venture, and Gimv. The Company also announced an exclusive global in-license and se ...

2020-11-30 - Kinaset Therapeutics Launches With $40 Million Series A to Advance Asthma Drug

Biotechnology startup Kinaset Therapeutics Inc. has launched with $40 million in venture financing to develop a drug that could make life easier for people with severe asthma. Asthma, a chronic disease that narrows and inflames air passages in the lungs, affects more than 339 million people glo ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16-20%N/A
#2
$1.4M16N/AN/A
#3
$0.5M16-11%$3.7M
#4
$0.5M160%$8.8M
#5
$2.3M16N/AN/A